Short description
Pulmonx provides minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.
Description
Pulmonx is the global leader in interventional procedures for the treatment of COPD. It develops and markets non-surgical technologies for the assessment and treatment of patients with severe emphysema, a progressive and life-threatening form of COPD. The Pulmonx solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The technology is supported by a compelling body of clinical evidence including over 100 published scientific articles regarding the clinical benefits of Zephyr Valves. FDA granted the Zephyr Valve a ‘breakthrough device’ designation, and in June 2018 Pulmonx received FDA pre-market approval to commercialize our Zephyr Valve. The Zephyr Valve is now commercially available and physicians in more than 25 countries around the world routinely use the Zephyr Valves to improve the lives of patients with severe emphysema, with over 76,000 valves used to treat more than 19,000 patients worldwide to date.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Redwood City, California, United States, North America
Founded on
January 1, 1998
Exited on
September 30, 2020
Went public on
September 30, 2020
Stock symbol
LUNG
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$56378 - 90123
Sign in for full access
Investors
Cannot Access, Cannot Access, Noaccess, Noway Youcantaccess, Cannot Access, Noaccess, Noway Youcantaccess, Absolutely Noaccess, Noaccess, Noaccess, Noway Youcantaccess, Noaccess, Cannot Access, Noaccess, Noway Youcantaccess, Blurry Noaccess, Uh Ohhhh, Noaccess
Sign in for full access
Founders
Rodney Perkins